AGE-RELATED IMMUNOGENICITY OF MENINGOCOCCAL POLYSACCHARIDE VACCINE INABORIGINAL CHILDREN AND ADOLESCENTS LIVING IN A NORTHERN MANITOBA RESERVE COMMUNITY
Bj. Law et al., AGE-RELATED IMMUNOGENICITY OF MENINGOCOCCAL POLYSACCHARIDE VACCINE INABORIGINAL CHILDREN AND ADOLESCENTS LIVING IN A NORTHERN MANITOBA RESERVE COMMUNITY, The Pediatric infectious disease journal, 17(10), 1998, pp. 860-864
Objective, To determine the total and functional serogroup C antibody
response to a quadrivalent meningococcal polysaccharide vaccine in a g
roup of aboriginal infants, children and adolescents. A secondary obje
ctive was to determine their prevalence of meningococcal carriage. Des
ign, Open prospective, before and after intervention study. Subjects,A
boriginal children ages 0.5 to 19.9 years, living in a single Northern
community and eligible for a public health immunization campaign cond
ucted in all Manitoba native reserve communities to control a meningoc
occal serogroup C, electrophoretic type (ET) 15 outbreak. No outbreak
cases had occurred in the community at the time of the study, Methods,
Total serogroup C capsular polysaccharide antibody (CPA) and function
al bactericidal antibody (BA) responses were measured by enzyme-linked
immunosorbent assay and bactericidal assay, respectively, Results. Ne
isseria meningitidis mas recovered from the oropharynx of 13 (5.2%) of
249 aboriginal children including 4 (1.6%) serogroup C isolates, all
with the designation C:2a:P1.2,5 ET15, Paired sera from 152 children w
ere available for assay, For CPA the geometric mean concentrations and
proportions with greater than or equal to 2 mu g/ml before and after
immunization were 0.69, 18% and 12.3, 96%, respectively. A significant
increase in serum CPA was achieved by children of all ages, with the
greatest response occurring after age 11 years. Among infants <1year o
ld 89% achieved concentrations of greater than or equal to 2 mu g/ml.
For BA the pre- and post-vaccine geometric mean titers were 1.02 and 4
5.9, The response was significantly associated with age. BA titers gre
ater than or equal to 1:8 mere present, before and after immunization,
respectively, in 0 and 0% of infants <1 year old, 0 and 20% of 1- to
1.4-year-olds, 0 and 50% of 1.5- to 1.9-year-olds and 1 and 100% of gr
eater than or equal to 2-year-olds. Conclusion. The age-related total
and functional group C meningococcal antibody response after quadrival
ent polysaccharide vaccine among aboriginals is similar to that report
ed for Caucasian children. After age 2 all children made excellent CPA
and BA responses. In the younger age groups the BA response was blunt
ed but 82 to 95% achieved CPA titers of greater than or equal to 2 mu
g/ml.